Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors For The Treatment Of Multiple Myeloma
Completed · Not applicable
Conditions studied: Multiple Myeloma
In brief
The purpose of the study is to determine the toxicity and feasibility of non-myeloablative allogeneic hematopoietic cell transplants for multiple myeloma from unrelated donors.
Key facts
- Study ID
- NCT00185653
- Run by
- Stanford University
- People needed
- 40
- Starts
- 2000-10-01
- Expected to finish
- 2008-11-01
- Last updated by the study team
- 2011-02-14
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.